A model for brain bilirubin uptake (BBU) predicts that BBU in jaundiced newborns typically depends on the plasma total bilirubin concentration (TBC) and the bilirubin-albumin dissociation rate constant (k 1 ) rather than the unbound bilirubin (B f ). The model's validity was tested by 1) evaluating its requirement that k 3 ϾϾϾ k 2 , where k 3 and k 2 are the rate constants for BBU and B f -albumin association, respectively, and 2) determining whether the calculated BBU is Յ5% of the bilirubin production rate, the approximate BBU expected if brain bilirubin levels are Ͻ1% of the miscible bilirubin pool as reported in the literature. The model was investigated using peroxidase test measurements of TBC, B f , k 1 , and k 2 from 185 jaundiced newborns. Mean k 2 was compared with the reported k 3 value of 0.08/s. BBU calculated from TBC and k 1 was expected to be Յ0.005 g/kg/s given the reported bilirubin production rate of 0.1 g/kg/s. BBU calculated using B f was also compared with the bilirubin production rate. The mean k 2 of 8.9 L/mol/s was greater than k 3 , and the mean BBU of 0.72 g/kg/s exceeded the expected range of Յ0.005 g/kg/s. However, mean BBU using B f (0.00073 g/kg/s) was within the expected range. A mathematical model calculating BBU as a function of TBC and k 1 could not be validated. BBU calculated from B f is consistent with the observation that Ͻ1% of the miscible bilirubin pool is distributed in the brain. The rate of BBU in jaundiced newborns is generally thought to be a function of the plasma non-albumin bound or "free" bilirubin (B f ), and current thinking is that this tiny fraction of the TBC is an important indicator of the risk of bilirubin toxicity (1-3). Recent publications by the American Academy of Pediatrics and the National Institutes of Health aimed at improving the clinical management of jaundiced newborns recommend, among other things, more research into the relationship between B f and bilirubin toxicity (4 -6).
The rate of BBU in jaundiced newborns is generally thought to be a function of the plasma non-albumin bound or "free" bilirubin (B f ), and current thinking is that this tiny fraction of the TBC is an important indicator of the risk of bilirubin toxicity (1) (2) (3) . Recent publications by the American Academy of Pediatrics and the National Institutes of Health aimed at improving the clinical management of jaundiced newborns recommend, among other things, more research into the relationship between B f and bilirubin toxicity (4 -6) .
B f is a function of the TBC, the fraction (␣) of TBC bound [␣ ϭ (TBC Ϫ B f )/TBC Ϸ 1 at clinically relevant TBC], the albumin concentration (A), and the bilirubin-albumin dissociation and association rate constants, k 1 and k 2 , respectively:
Because B f is Ͻ 0.1% of plasma bilirubin but only about 90% of plasma bilirubin may be bound to albumin in adults (7) , A in equation 1 may be considered the "average" concentration of all the plasma species reversibly binding bilirubin (e.g., HDL) and k 1 and k 2 the "average" constants without fundamentally changing the arguments that follow. Several recent studies suggest that B f as measured by the peroxidase test is indeed a more sensitive and specific indicator of bilirubin toxicity than the TBC alone (3,8 -10) .
Despite these considerations, the clinical management of jaundiced newborns is conventionally based on the less reliable but readily obtainable TBC (4) . Although this approach has been questioned (11) , there is an often-overlooked but important paper that supports, in theory, the use of the TBC in most clinical situations. About 18 y ago, Robinson and Rapoport applied a general mathematical model they had developed for brain uptake of protein bound drugs to BBU (12, 13) . Their model predicts that at TBC levels below about 454 M (27 mg/dL), the plasma factors determining BBU are TBC and k 1 . B f becomes important only when the TBC is above 27 mg/dL or unusual circumstances are present (e.g., drugs that interfere with plasma bilirubin binding). Because k 1 is a constant, BBU will therefore be directly proportional to TBC.
According to their model, as blood enters the cerebral capillaries, B f is instantaneously taken up at a rate given by Ϫk 3 ⅐ B f , where k 3 is the net first order rate constant for brain uptake of bilirubin (they estimate k 3 Ϸ0.08/s) (13) . The instantaneous change in B f caused by Ϫk 3 ⅐ B f perturbs the equilibrium B f (B feq ) at which dB feq /dt is zero per equation 2 below, and B feq rapidly falls to the steady state level B fss , where dB fss /dt remains close to zero (equation 3) for the remainder of the trip through the capillaries.
Since dB fss /dt Ϸ 0, equation 3 can be rearranged to give:
The general model (12) assumes that the perturbation of equilibrium (Ϫk 3 ⅐ B eq ) is of such magnitude that B fss Ͻ Ͻ Ͻ B feq , generating the inequalities
Under these circumstances, equation 4 becomes:
From equation 5, it follows directly that BBU ϭ k 3 ⅐ B fss Ϸ k 1 ⅐ ␣ ⅐ TBC, the basis of the Robinson and Rapoport model. By combining the capillary transit time, ␣ (Ϸ1), k 1 , and k 3 into the constant E (see equation 9 in "Methods"), which is the fraction of the TBC extracted during passage through the capillaries, they obtained equation 6, which gives BBU as a function of cerebral blood flow, the constant E, and the TBC (12,13):
The Robinson and Rapoport model for BBU has never been validated, but it exists in the literature as credible support (assuming little variability in the constants) for using only the TBC, at least when managing jaundiced but otherwise well term newborns whose TBC levels are below 27 mg/dL. In this study, we use measurements of TBC, B f , k 1 , and k 2 from a diverse population of jaundiced newborns to investigate the validity of their model by testing 1) whether k 2 ⅐ [A Ϫ (␣ ⅐ TBC)] ϽϽ Ͻ k 3 is a valid assumption in the derivation of their model (see equations 4 and 5), and 2) whether BBU calculated by substituting actual TBC and k 1 measurements into equation 6 yields BBU values that are about 5% of the reported rate of bilirubin production (14) , a necessary condition if the BBU is to produce brain bilirubin levels that are Ͻ1% of the miscible bilirubin pool as reported in the literature (15, 16) .
METHODS

Population.
We reviewed the medical records of 256 newborns who received plasma TBC and B f measurements as part of their evaluation for newborn jaundice to obtain a set of TBC values and their corresponding B f , k 1 , k 2 , and albumin concentration for use in the study as outlined below. The review of medical records for this purpose was approved by the California Pacific Medical Center Institutional Review Board.
Hypotheses to Be Evaluated. 1) K 2 < < < K 3 . Equation 5 depends on the inequality k 2 ⅐ [A Ϫ (␣ ⅐ TBC)] Ͻ Ͻ Ͻ k 3 , and Robinson and Rapoport estimate that k 3 is about 0.08/s (13) . Inasmuch as A Ϫ (␣ ⅐ TBC) will be numerically greater than 0.08 at all the TBC and albumin levels of the population, k 2 ⅐ [A Ϫ (␣ ⅐ TBC)] Ͻ Ͻ Ͻ k 3 will be true only if k 2 Ͻ Ͻ Ͻ k 3 . We therefore tested the validity of the inequality k 2 ⅐ [A Ϫ (␣ ⅐ TBC)] Ͻ Ͻ Ͻ k 3 by determining whether k 2 was substantially less than 0.08. If the assumption is not valid and the hypothesis rejected, all the mass action factors (TBC, A, k 1 , and k 2 ) are the relevant plasma factors determining B fss per equation 4.
2) BBU calculated using TBC and k 1 (equation 6) will be Յ0.005 g/kg/s. The mean bilirubin production rate reported for well, term newborns is 8.5 mg/kg/24 h or 0.10 g/kg/s (14) . Since it is estimated that Ͻ1% of the miscible bilirubin pool distributes in the brain (15, 16) , the model, if valid, should provide rates of BBU somewhere in the neighborhood of 5% or less (Յ0.005 g/kg/s) of the bilirubin production rate. For example, assume BBU is 5% of the bilirubin production rate and that the bilirubin excretion rate is 60% of the production rate (14) . If 10% of the cardiac output is directed to the brain and x mg of bilirubin are produced in a period of time, 0.005x will be taken up by the brain and 0.6x will be excreted. Of the 0.4x remaining in the miscible bilirubin pool, 1.25% (0.005/0.4) will reside in the brain.
Measurement of TBC, B f , k 1 and k 2 . TBC and the B f were measured using an FDA-approved peroxidase method (Arrows UB Analyzer, Arrows Co., Ltd., Osaka, Japan) (17) . HRP (EC 1.11.17) catalyzed oxidation of B f by peroxide was measured at HRP concentrations of 23.8 g/mL (0.54 M) and 11.9 g/mL to obtain B f1 and B f2 , respectively. Two HRP concentrations are used to avoid underestimating B feq because, just as Ϫk 3 ⅐ B feq perturbs B feq during BBU (see equations 2 and 3), the onset of B f oxidation, which is given by Ϫk p ⅐ [HRP] ⅐ B feq , where k p is the bilirubin oxidation rate constant per unit HRP concentration (18) 
In contrast to the requirement that k 2 ⅐ [A Ϫ (␣ ⅐ TBC)] Ͻ Ͻ Ͻ k 3 for the Robinson and Rapoport model (12) , the peroxidase test requires kp 
In this circumstance (and assuming ␣ ϭ 1), k 1 can be obtained from the slope of equation 8 as k 1 ϭ k p /(TBC ⅐ slope), following which k 2 can be obtained from the intercept as k 2 ϭ intercept ⅐ k 1 ⅐ TBC/(A ϪTBC) (19) . The mean k p for the stock peroxidase was 18/s per mol/L of HRP (SD 1.1, n ϭ 16). An important caveat is that sample dilution alters bilirubin-albumin binding in plasma as well as purified albumin solutions (20, 21) . B feq at the 42-fold sample dilution used in this study is likely to be much smaller than B feq in the undiluted sample, but it has been shown that the levels do correlate linearly (22) . Dilution appears to primarily affect k 2 rather than k 1 (23) and because B f is usually 2-to 5-fold lower at a 42-fold sample dilution (20, 21) , the impact of an order of magnitude increasein B feq or decrease ink 2 on the results was taken into consideration when analyzing the data.
Calculation of BBU by equation 6 (the Robinson and Rapoport model). BBU was calculated for each sample using equation 6 
Inserting E for the sample along with the measured TBC and a cerebral blood flow of 0.5 mL/s/kg obtained from the reported blood flow rate 0.5 mL/s/100 g of brain (24) and a brain weight of 100 g/kg (25) into equation 6 provided BBU according to the Robinson and Rapoport model as:
Calculation of BBU using B f . If BBU is determined primarily by B f , the instantaneous decrease in B feq as blood enters the brain capillaries is given by:
Integrating equation 11 between the time that blood enters the capillary (t ϭ 0) and the time it exits the capillary () during which B feq falls to B fss , one obtains:
The fraction of B feq removed on passing through the brain capillaries, comparable to E in equation 10, is:
Fraction of B f extracted ϭ 1 Ϫ B fss B eq ϭ 1 Ϫ e Ϫ k3 ⅐ , and therefore
If k 3 ϭ 0.08/s and ϭ 1.75 s, BBU is given as:
RESULTS
A total of 293 B f measurements were made in a population of 256 jaundiced newborns. Of these, 198 samples from 185 newborns had B f2 levels that exceeded B f1 by 5% or more (mean 17%, SD 11%, range 6 -69%). The mean birth weight and gestational age were 2401 g (SD ϭ 1103, range 406 -4483, n ϭ 185) and 34 wk (SD 5, range 24 -42 wk, n ϭ 185), respectively. The mean TBC and B f were 15.3 mg/dL (SD 7.0, range 2.8 -34.2) and 1.12 g/dL (SD 0.89, range 0.11-7.63), respectively. The mean B f1 and B f2 were 0.77 g/dL (SD 0.55, range 0.09 -3.83, n ϭ 198) and 0.90 g/dL, SD 0.66, range 0.10 -5.1), respectively. Albumin was measured in 181 samples (91%), and the mean was 3.4 g/dL (SD 0.7, range 1.0 -4.7). The various constants are given according to birth weight in Table 1 .
Is k 2 < << k 3 ?
The mean k 2 ( Table 1 ) was 8.9 L/mol/s, which is numerically about 100 times greater than k 3 (0.08). Even if undiluted plasma has a mean k 2 two orders of magnitude less (0.089 L/mol/s), the assumption required by the Robinson and Rapoport model that k 2 ⅐ [A Ϫ (␣ ⅐ TBC)] ϽϽ Ͻ k 3 will not be valid. Review of the literature provided no evidence that k 3 might be substantially larger than 0.08/s (26) , and assuming A underestimates the total concentration of bilirubin binding sites only reinforces the conclusion that the assumption is not valid.
Is BBU <0.005 g/kg/s? The mean k 1 (Table 1 ) was 0.093/s. E calculated by equation 9 ranged from 0.001 to 0.036 (mean 0.010, SD 0.006), indicating that as little as 0.1% to as much as 3.6% of the TBC according to the model would be extracted as blood passed through the cerebral capillaries.
The mean BBU calculated using equation 10 (Robinson and Rapoport model) was 0.72 g/kg/s (SD 0.52, range 0.057-2.7), with the calculated BBU exceeding the reported bilirubin production rate of 0.1 g/kg/s in 193 of 198 samples (97%). Assuming BBU equals the bilirubin production rate (it could not proceed any faster), about 25% of the miscible bilirubin pool rather than the reported Ͻ1% should be found in the brain.
The mean BBU as a function of B f (equation 15) was 0.00073 g/kg/s (SD 0.00058, range 0.000073-0.0050), which is 0.73% of the bilirubin production rate and much more in line with the anticipated BBU of Յ0.005 g/kg/s. Interestingly, if B f is actually an order of magnitude higher in undiluted plasma (20 -22) , BBU would be about 7% of the bilirubin production rate and about 1.8% of the miscible bilirubin pool would be expected to reside in the brain. This is still very close to the value expected, and BBU by the total bilirubin model would either be the same or increase depending on the degree to which k 1 is affected by dilution (k 2 /k 1 decreases as B f increases requiring some combination of a decrease in k 2 and/or increase in k 1 ). Even if k 2 is an order of magnitude smaller, it still is 10-fold higher than k 3 .
DISCUSSION
Our results show that the Robinson and Rapoport mathematical model predicting that BBU will be largely a function of the TBC at TBC levels below 27 mg/dL is invalid when measured values for TBC and the bilirubin-albumin dissociation rate constant (k 1 ) along with constants from the literature for brain bilirubin blood flow, capillary transit time (), and brain bilirubin uptake (k 3 ) are applied to the model. B feq when k 3 ϭ 0.08/s and ϭ 1.75 s will not fall sufficiently in the cerebral capillaries to meet the assumptions required for equation 5 to be operative. For the Robinson and Rapoport model to be operative, the expression e Ϫk 3 ⅐ in equation 13 must be nearly zero, indicating that virtually 100% of the B f is taken up within a few milliseconds of the blood entering the capillary. This requires Ϫk 3 ⅐ to be much greater than previously reported. Since is unlikely significantly greater, k 3 in humans would need to be orders of magnitude larger than the values reported in animals. Even assuming k 3 ϭ 80/s (1000-fold higher than the value in animals), at the mean k 2 of our study (8.9 L/mol/s), a TBC of 10 mg/dL (171 M), and the mean study albumin of 3. Thus, all the plasma mass action variables determining BBU must be operative (TBC, A, k 1 , and k 2 ), and because the fraction of bilirubin extracted during brain capillary transit is constant (equation 15), the overall amount of bilirubin taken up by the brain during capillary transit will be a function of B feq .
Our bilirubin-albumin binding data were from a diverse population of jaundiced newborns to provide a wide range of binding variables for the models, and because it was not possible to measure the bilirubin production rate, bilirubin pool distribution, and cerebral blood flow for each newborn, we applied our best estimate of each variable to the population. Variation in cerebral blood flow would apply to both models equally (equations 10 and 14) and not change the results. Because BBU by the Robinson and Rapoport model is 1000-fold greater than that by the B f model, the BBU as a percentage of bilirubin production rate would not change greatly with variation in bilirubin production (even at triple the bilirubin production rate as occurs in hemolysis (14) BBU by the Robinson and Rapoport model still exceeds the production rate and BBU by the B f model remains below 1% of the production rate). The percentage of the miscible bilirubin pool residing in the brain could also be in error by an order of magnitude (10% versus Ͻ1%) and BBU by the Robinson and Rapoport model would still far exceed the BBU predicted.
Considering the above, it is not unexpected that the BBU calculated according to the model (equation 10) was far too high relative to the bilirubin production rate for the model to be considered an accurate representation of BBU. BBU rates calculated using B f as the operative plasma species (equation 15), however, are within the range expected assuming the reports that Ͻ 1% of the miscible bilirubin pool distributes in the brain are reasonably accurate and applicable to human newborns (15, 16) . Although sample dilution may systematically alter the binding variables (20 -23) , even when order of magnitude errors in the variables are invoked, the Robinson and Rapoport model still fails.
It is ironic that were the model correct, the variability in k 1 (Table 1) would still require routine measurement of bilirubinalbumin binding, but the desired result would usually be k 1 (to calculate E) rather than B f . This paradoxical "inconstancy" of constants (Table 1) is a subtle but important reminder that there is considerable variability in plasma bilirubin binding in jaundiced newborns. If not, B f could be calculated from the TBC and albumin, assuming albumin binds most of the bilirubin in plasma (7) We found a 73% coefficient of variation in k 1 and a 158% variation in the equilibrium association constant (k 2 / k 1 ). Cashore (27) , using the peroxidase test and a single peroxidase concentration, has reported a 40% coefficient of variation for k 2 /k 1 in well term newborns. The reasons for this variability are mostly unknown, but albumin dimerization and polymorphism (28) and small competing molecules generated during illness (29) may contribute. Variability in the nonplasma factors that can alter individual susceptibility to bilirubin toxicity, including interindividual variability in BBU, also deserve more study (30) .
The Robinson and Rapoport model cannot be used as evidence supporting the use of the TBC alone when evaluating jaundiced newborns in any circumstances. Our data suggest that even if significant non-albumin binding of bilirubin in plasma occurs, B f as measured by the peroxidase test provides rates of BBU consistent with the reported bilirubin production rate and miscible bilirubin pool distribution. Continued investigation of the usefulness of B f measured in minimally diluted plasma (22) as an adjunct in the evaluation of newborn jaundice seems warranted.
